Alnylam Pharmaceuticals Inc
Closed
SectorHealthcare
311.84 3.09
Overview
Share price change
24h
Min
309.87
Max
313.13
Income | 20M 206M |
|---|---|
Sales | 70M 1.2B |
P/E Sector Avg | 73.025 56.269 |
EPS | 1.99 |
Profit margin | 17.649 |
Employees | 2,500 |
EBITDA | 159M 304M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +46.66% upside |
Next Earnings | 30 lip 2026 |
|---|
Market Cap | -2.3B 39B |
|---|---|
Previous open | 308.75 |
Previous close | 311.84 |
News Sentiment
By Acuity
50%
50%
156 / 342 Ranking in Healthcare
Alnylam Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Alnylam Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 458.73 USD 46.66%
High 550 USD
Low 370 USD
Based on 19 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$